Evidence map›Paper›PMID 30406039›Full record

ReviewFrontiers in cellular and infection microbiology2018

Autophagy, EVs, and Infections: A Perfect Question for a Perfect Time.

Michelle L Pleet, Heather Branscome, Catherine DeMarino, Daniel O Pinto, Mohammad Asad Zadeh, Myosotys Rodriguez, Ilker Kudret Sariyer, Nazira El-Hage, Fatah Kashanchi

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Exosome-Autophagy Crosstalk in Enveloped Virus Infection.International journal of molecular sciences · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Targeting autophagy with natural products to prevent SARS-CoV-2 infection.Journal of traditional and complementary medicine · 2022
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Michelle L PleetLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.
Heather BranscomeLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.
Catherine DeMarinoLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.
Daniel O PintoLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.
Mohammad Asad ZadehLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.
Myosotys RodriguezDepartment of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Ilker Kudret SariyerDepartment of Neuroscience, Center for Neurovirology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States.
Nazira El-HageDepartment of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Fatah KashanchiLaboratory of Molecular Virology, School of Systems Biology, George Mason University, Manassas, VA, United States.

Funding

HIV1 INHIBITION USING TAT PEPTIDE DERIVATIVESR01AI043894 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI KASHANCHI, FATAH · 1999 to 2015
$4.4M
HIV neuropathogenesis related to exosomes containing HIV non-coding RNAsR01NS099029 · NINDS · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2020
$1.9M
Role of Autophagy in Microglia-induced NeuroAIDS in Substance AbuseR01DA036154 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI EL-HAGE, NAZIRA · 2013 to 2017
$1.9M
Effect of chromatin remodelers/modifiers on HIV-1 Tat activated transcriptionR21AI074410 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$432k
A radiation-induced cellular stress activates HIV and induces killing of infected cellsR21AI127351 · NIAID · GEORGE MASON UNIVERSITY · PI KASHANCHI, FATAH · 2016 to 2017
$418k
HIV-1 TAR derived miRNA: Implications for Latency and PathogenesisR21AI078859 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI KASHANCHI, FATAH · 2009 to 2010
$400k
Impact of μ-opioid receptor (MOR) splice variant interactions with the chemokine receptor CCR5 in the context of morphine and HIV-1 entry inhibitor therapyR21DA041287 · NIDA · FLORIDA INTERNATIONAL UNIVERSITY · PI EL-HAGE, NAZIRA · 2016 to 2017
$363k
NIAID NIH HHS R01 AI043894NIAID NIH HHS R21 AI074410NIAID NIH HHS R21 AI078859NIAID NIH HHS R21 AI127351NIDA NIH HHS R01 DA036154NIDA NIH HHS R21 DA041287NINDS NIH HHS R01 NS099029
6 · The paper itself

Abstract

Autophagy, a highly conserved process, serves to maintain cellular homeostasis in response to an extensive variety of internal and external stimuli. The classic, or canonical, pathway of autophagy involves the coordinated degradation and recycling of intracellular components and pathogenic material. Proper regulation of autophagy is critical to maintain cellular health, as alterations in the autophagy pathway have been linked to the progression of a variety of physiological and pathological conditions in humans, namely in aging and in viral infection. In addition to its canonical role as a degradative pathway, a more unconventional and non-degradative role for autophagy has emerged as an area of increasing interest. This process, known as secretory autophagy, is gaining widespread attention as many viruses are believed to use this pathway as a means to release and spread viral particles. Moreover, secretory autophagy has been found to intersect with other intracellular pathways, such as the biogenesis and secretion of extracellular vesicles (EVs). Here, we provide a review of the current landscape surrounding both degradative autophagy and secretory autophagy in relation to both aging and viral infection. We discuss their key features, while describing their interplay with numerous different viruses (i.e. hepatitis B and C viruses, Epstein-Barr virus, SV40, herpesviruses, HIV, chikungunya virus, dengue virus, Zika virus, Ebola virus, HTLV, Rift Valley fever virus, poliovirus, and influenza A virus), and compare secretory autophagy to other pathways of extracellular vesicle release. Lastly, we highlight the need for, and emphasize the importance of, more thorough methods to study the underlying mechanisms of these pathways to better advance our understanding of disease progression.

Indexed as

AutophagyVirus ReleaseAgingAnimalsExtracellular VesiclesHumansVirus DiseasesVirusesautophagyexosomeextracellular vesicleinfectious diseasesecretory autophagyvirus

Identifiers

PMID30406039
PMCPMC6201680

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.